Effects of Flourish HEC on Localized Provoked Vulvodynia
NCT05478746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2024-02-06
Summary
This study is designed to determine whether improving the vaginal microbiome in women with localized provoked vulvodynia (LPV) may help improve pain better than routine care alone. The study randomizes women with LPV to either routine care or routine care plus a vaginal hygiene system designed to improve the vaginal microbiome. Women will be assessed for vaginal microbiome, vaginal pH, and pain before enrollment and after 6 weeks, and after 3 months. Women will also have pain assessed 2 weeks after enrollment without assessing vaginal microbiome and pH.
Conditions
- Vulvodynia
- Vestibulodynia
- Vulvar Diseases
- Vulvar Vestibulitis
- Vulvar Pain
Interventions
- DEVICE
-
BioNourish, a component of the Flourish HEC kit
BioNourish is a vaginal moisturizing gel which obtained FDA 510k clearance in 2020. It is one component of the full system being tested. The main intervention is to use this kit to improve the vaginal microbiome.
- OTHER
-
Control - no intervention
No intervention; participants only receive routine care.
Sponsors & Collaborators
-
Evvy
collaborator UNKNOWN -
Vaginal Biome Science
lead OTHER
Principal Investigators
-
Mary Ojo-Carons, MD · EvoScient Gynecology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 52 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-26
- Primary Completion
- 2024-01-15
- Completion
- 2024-01-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
CC-10004 For The Treatment Of Vulvodynia
NCT00814632 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
NCT00590590 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Lactobacillus in Adjuvant Treatment of RVVC
NCT04699240 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Protocol CERN Feasibility Study
NCT06933420 ·Status: RECRUITING ·Phase: NA
-
Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation
NCT01899612 ·Status: COMPLETED
-
Young Vulvodynia: Effect and Efficacy of Multimodal Treatment.
NCT07092332 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NCT06983041 ·Status: RECRUITING ·Phase: NA
-
EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS
NCT05649735 ·Status: COMPLETED ·Phase: NA
-
Transplantation of Vaginal Mikrobiome
NCT04855006 ·Status: COMPLETED ·Phase: NA
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
NCT05753813 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
NCT07109869 ·Status: RECRUITING ·Phase: PHASE3
-
The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantation
NCT05963711 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH
NCT05060029 ·Status: UNKNOWN ·Phase: PHASE4
-
DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)
NCT04370548 ·Status: COMPLETED ·Phase: PHASE3
-
DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy
NCT06397248 ·Status: RECRUITING
-
Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
NCT05361369 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
NCT02569697 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Group Study to Evaluate the Effects of a pH Balanced Cleanser on Women's Intimate Health.
NCT06516731 ·Status: COMPLETED ·Phase: NA
-
Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis
NCT05012852 ·Status: UNKNOWN ·Phase: NA
-
Light Treatment of Vaginal Infections in Reproductive Age Women
NCT06985433 ·Status: COMPLETED ·Phase: NA
-
First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories
NCT05340790 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Study to Treat Bacterial Vaginosis
NCT01621399 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Ketotifen 0.25% for Secondary Vestibulodynia
NCT07257029 ·Status: RECRUITING ·Phase: PHASE2
-
Vaginal Flora for Treatment of Bacterial Vaginosis
NCT02236429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis
NCT04640922 ·Status: COMPLETED ·Phase: NA